Publications by authors named "Xiushan Feng"

Claim this Profile
C
CIK-augmented anti-PD1/CTLA4 immunotherapy eradicates chemo-resistant ovarian cancer via tripartite mechanistic synergy.
Peifang Chen, Jianrong Pan, Ling Chen, Xiushan Feng

Front Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRIM22 governs tumorigenesis and protects against endometrial cancer-associated cachexia by inhibiting inflammatory response and adipose thermogenic activity.
Liping Zhang, Quanrong Li, Meiting Wu, Xiushan Feng, Weichao Dai

Cancer Metab· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human thrombopoietin therapy for primary immune thrombocytopenia in pregnancy: a retrospective comparative cohort study.
Jing Lin, Tong-Fei Wang, Mei-Juan Huang, Hao-Bo Huang, Pei-Fang Chen, Xiu-Shan Feng

BMC Pregnancy Childbirth· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role and mechanism of the p-JAK2/p-STAT3 signaling pathway in follicular development in PCOS rats.
Huilan Wang, Xiushan Feng, Tongfei Wang, Jianrong Pan, Zhiqun Zheng

Gen Comp Endocrinol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental study for the establishment of a chemotherapy-induced ovarian insufficiency model in rats by using cyclophosphamide combined with busulfan.
Dongyuan Tang, Xiushan Feng, Li Ling, Wenqian Zhang, Yanjing Luo

Regul Toxicol Pharmacol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells.
Huixi Weng, Xiushan Feng, Yu Lan, Zhiqun Zheng

J Ovarian Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Human Amnion-Derived Mesenchymal Stem Cell (hAD-MSC) Transplantation In Situ on Primary Ovarian Insufficiency in SD Rats.
Xiushan Feng, Li Ling, Wenqian Zhang, Xiaohan Liu, Yaping Wang

Reprod Sci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nck1 promotes the progression of ovarian carcinoma by enhancing the PI3K/AKT/p70S6K signaling.
Xiaohan Liu, Jing Zhang, Zhaoning Duan, Xiushan Feng, Yang Yu

Hum Cell· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism.
Li Ling, Xiushan Feng, Tianqin Wei, Yan Wang, Yaping Wang

Stem Cell Res Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear factor 90 promotes angiogenesis by regulating HIF-1α/VEGF-A expression through the PI3K/Akt signaling pathway in human cervical cancer.
Wenqian Zhang, Zhengai Xiong, Tianqin Wei, Qiumeng Li, Ying Tan, Xiushan Feng

Cell Death Dis· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-intensity pulsed ultrasound activates ERK1/2 and PI3K-Akt signalling pathways and promotes the proliferation of human amnion-derived mesenchymal stem cells.
Li Ling, Tianqin Wei, Lianli He, Yaping Wang, Yan Wang, Xiushan Feng

Cell Prolif· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of low-intensity pulsed ultrasound (LIPUS)-pretreated human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation on primary ovarian insufficiency in rats.
Li Ling, Xiushan Feng, Tianqin Wei, Yan Wang, Yaping Wang

Stem Cell Res Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis